Dr. Reddy's Laboratories gains on planning to raise funds through CP

25 Mar 2020 Evaluate

Dr. Reddy's Laboratories is currently trading at Rs. 2865.15, up by 6.50 points or 0.23% from its previous closing of Rs. 2858.65 on the BSE.

The scrip opened at Rs. 2858.00 and has touched a high and low of Rs. 2920.00 and Rs. 2797.70 respectively. So far 8333 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3363.00 on 20-Feb-2020 and a 52 week low of Rs. 2352.00 on 14-Aug-2019.

Last one week high and low of the scrip stood at Rs. 3187.00 and Rs. 2497.60 respectively. The current market cap of the company is Rs. 47856.73 crore.

The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 45.14% and 13.80% respectively.

Dr. Reddy's Laboratories is planning to raise funds by issuance of Commercial Paper (CP). The meeting of company’s Board of Directors will be held on March 27, 2020 to consider and approve the same.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1208.45 -15.85 (-1.29%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×